HeberFERON® en el cáncer de piel no melanoma en zona H de la cara

Janet González Arencibia; Midalys Ramos Trujillo; Rocío Gómez Quezada

doi:10.56294/sctconf2022248

Conference abstract

Published: 2022-12-12

DOI: https://doi.org/10.56294/sctconf2022248

HeberFERON® in non-melanoma skin cancer on the H-zone of the face

Abstract

Introduction: HeberFERON has shown excellent results in the solution of skin cancer located in the facial region, specifically basal cell carcinoma (BCC), constituting a less traumatic alternative for its treatment.

Objective: to describe the results of the application of HeberFERON in patients with BCC who attended dermatology consultation at the Luis Augusto Turcios Lima Polyclinic in Pinar del Río, from January 2020 to December 2021.

Methodology: a series study of clinical cases with diagnosis of BCC was carried out. Thirty cases were included with clinical diagnosis, by dermatoscopy and histopathological study by biopsy, located in the anatomical region called zone H of the face. They were treated with HeberFERON in different 3-week cycles according to response. They were reevaluated by dermoscopy between 8 and 16 weeks after the end of the treatment.

Results: together with female sex, skin phototype II, location on the dorsum of the nose, and ulcerated clinical and histological subtype were the most frequent. All cases showed complete response.

Conclusions: the effectiveness of treatment with HeberFERON is shown in a series of 30 cases diagnosed with BCC. Among the main adverse reactions shown were: fever, chills and erythema at the infiltration site. This study shows that HeberFERON is a therapeutic option to avoid mutilations in the H-zone of the face, which makes its use advisable in cases diagnosed with non-melanoma skin cancer.

Keywords:

Interferons/Therapeutic Use,

Interferons/Administration and Dosage,

Basal Cell Carcinoma,

Basal Cell Carcinoma/Pharmacologic Treatment,

Case Series,

How to Cite

González Arencibia J, Ramos Trujillo M, Gómez Quezada R. HeberFERON® in non-melanoma skin cancer on the H-zone of the face. Salud, Ciencia y Tecnología - Serie de Conferencias [Internet]. 2022 Dec. 12 [cited 2024 Jun. 29];1:248. Available from: https://conferencias.saludcyt.ar/index.php/sctconf/article/view/248

Copyright Notice

The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.

Article metrics

Google scholar: See link

Metrics

Metrics Loading ...

Vol. 1 (2022)

See full issue

Revistas / Journals

Issue

About

Author Guidelines